GlassScriptPhysician profile
Aaron L Fetty
NPI 1215553219
$4,863.39
in general payments reported to CMS, 2019-2025
23 companies · $2,256 in 2025
The $2,256 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $395 · 2022: $540 · 2023: $764 · 2024: $908 · 2025: $2,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,947 · Travel and Lodging: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,946.64 |
| Travel and Lodging | $981.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,148.27 | 2021-2025 | Watchman Access System, Watchman Flx, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $825.17 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $382.12 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $313.17 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $142.34 | 2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $137.63 | 2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $132.36 | 2021-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $131.13 | 2024-2025 | Eliquis, Camzyos |
| Janssen Scientific Affairs, LLC | $101.25 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $86.14 | 2022-2024 | Farxiga, Wainua, Brilinta |
| Recor Medical INC | $65.98 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Pfizer INC. | $57.82 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $54.91 | 2023 | Verquvo |
| Atricure, INC. | $45.31 | 2022 | |
| Abiomed | $37.95 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $37.64 | 2023 | Optimizer |
| Medtronic, INC. | $35.83 | 2023-2024 | Corevalve Evolut R |
| Siemens Medical Solutions USA, INC. | $33.95 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.96 | 2024-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $27.63 | 2024 | Evkeeza |
| Heartflow, INC. | $14.09 | 2025 | |
| Sanofi-Aventis U.S. LLC | $12.69 | 2023 | |
| Vifor Pharma, INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Fetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.